Literature DB >> 20148711

Investigation of self-microemulsifying and microemulsion systems for protection of prednisolone from gamma radiation.

Gamal M El Maghraby1, Ahmed A Bosela.   

Abstract

Radiation is efficient for terminal sterilization. Unfortunately, its use for liquid pharmaceuticals is difficult. This work investigated the potential radioprotective effect of self-microemulsifying (SMEDDS), microemulsions and their phase transition systems which were reported to enhance ocular drug delivery. Prednisolone solutions were prepared in SMEDDS, W/O microemulsions containing, 5% w/w (ME 5%) or 10% w/w (ME 10%) water, liquid crystalline system with 25% water (LC) and coarse emulsion containing 80% water (EM). These were subjected to gamma irradiation with aqueous solution and suspension being used as control. The physical properties of the formulations were monitored and the chemical potency of the drug was determined using a stability indicating HPLC method. The phase behavior of the formulations was not affected by irradiation but the viscosity of LC was significantly reduced. The SMEDDS, ME 5% and ME 10% showed excellent radiation protection as indicated by no change in the chemical potency. The LC retained 84% and the EM retained 39.8% of the chemical potency after exposure to 20 KGy. The aqueous solution was extensively degraded with the suspension retaining only 73.5% of the potency at 20 KGy. SMEDDS and W/O microemulsion can thus protect prednisolone from degradation by ionizing radiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148711     DOI: 10.3109/10837451003610829

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  1 in total

1.  Stability, cutaneous delivery, and antioxidant potential of a lipoic acid and α-tocopherol codrug incorporated in microemulsions.

Authors:  Siji Thomas; Camila S Vieira; Martha A Hass; Luciana B Lopes
Journal:  J Pharm Sci       Date:  2014-06-24       Impact factor: 3.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.